Influenza Updates - 2020 season

IMPORTANT INSEASON UPDATE:

IMPORTANT AFLURIA QUAD UPDATE

BP Medical is here to help. We are pleased to advise we have secured additional stock that can be ordered if you still require doses for your community.
We have seen a significant increase in demand as various industries push for Influenza Vaccines to become mandatory or highly recommended for all staff. These industries include Aged Care, Childcare, Education, Sports and Recreation and many more.
As we start to gradually see COVID-19 restrictions lifted, we can only predict the demand to increase further.

Stock is due Mid-June. Demand indicates that stock will sell out quickly.

DON’T MISS OUT, SECURE YOUR STOCK - PLACE YOUR ORDER TODAY.
All orders are final, BP Medical Supplies reserves the right to not accept cancellation of orders once placed.

Please read below for information regarding your favourite Influenza brands and the 2020 Influenza Season.

The Australian Influenza Vaccine Committee (AIVC) met at TGA, Canberra, on Wednesday 9th October 2019, to recommend influenza viruses to be used in the composition of the influenza vaccines for 2020. During this meeting, the expert committee reviewed and evaluated data related to epidemiology, antigenic and genetic characteristics of recent influenza isolates circulating in Australia and the Southern Hemisphere, serological responses to 2018-2019 vaccines, and the availability of candidate vaccines viruses and reagents.

2020 Composition of Influenza vaccine

The committee recommended that the following viruses be used for influenza vaccines in the 2020 southern hemisphere influenza season:

Egg based Quadrivalent influenza vaccines:

· an A/Brisbane/02/2018 (H1N1)pdm09-like virus;

· an A/South Australia/34/2019 (H3N2)-like virus;

· a B/Washington/02/2019-like (B/Victoria lineage) virus; and

· a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.

The AIVC recommendation for the composition of influenza vaccines for Australia in 2020 introduces a new A (H1N1) like virus strain, a new A (H3N2) like virus strain and new strain for the B Victoria lineage when compared to the composition of the trivalent and quadrivalent vaccines for Australia in 2019.

The TGA has accepted the recommendations of the AIVC.

For more information please head to: https://www.tga.gov.au/aivc-recommendations-composition-influenza-vaccine-australia-2020

Influenza Vaccines

Afluria Quad – Afluria Quad can be administered to those aged from 5 years and above. It is not suitable for anyone under the age of 5. View CMI, View PI. Needles included in the box.
FluQuadri – FluQuadri can be administered to children aged 6 months and above. It is suitable to adults of all ages View CMI, View PI. Needles included in the box (25G x 1inch).

Over 65+

Fluzone High-Dose (Not available to Australian market in 2020).
Fluad Quad (Only available on the NIP) - It can be administered to adults aged 65 years and above. View CMI, View PI

2019 Season Summary

There were a total of 310,011 laboratory confirmed notifications of Influenza in Australia for 2019. (As at start of 17.12.2019)

ACT: 4,020
NSW: 115,500
NT: 1,638
QLD: 67,639
SA: 26,862
TAS: 3,109
VIC: 68,176
WA: 23,067

Source: https://www.immunisationcoalition.org.au/news-media/2019-influenza-statistics/

Timing of Influenza vaccination:

Annual influenza vaccination is recommended before the influenza season starts. Influenza circulation usually peaks between June and September in most parts of Australia.
However, influenza can occur year-round, especially in tropical areas.

People can receive influenza vaccine from the time the vaccine becomes available, typically in March or April. The exact timing can vary from year to year.

Protection is expected to last for the whole season, but optimal protection is within the first 3–4 months after vaccination. Deferring vaccination to the beginning of winter may result in greater immunity later in the season, but may also result in missed opportunities for vaccination and lack of protection if the influenza season starts early.

Source: https://immunisationhandbook.health.gov.au/vaccine-preventable-diseases/influenza-flu

Can you be sure that your vaccines are arriving uncompromised?

We adhere to strict Cold Chain procedures. We delivered over 1.75 Million doses of vaccines successfully in 2019!

We ensure the required temperatures (2-8°C) are maintained throughout the journey

Our vaccines are packed inside our purpose-built cool room by our staff.
Ice bricks are correctly conditioned to avoid any chill factor.
Orders are shipped in eskies or in validated cold trucks.

We include TagAlert Monitors in every order

All our vaccines deliveries, whether delivered by cold truck or esky, include a highly accurate TagAlert indicator.
The TagAlert measures the storage temperature throughout transportation and detects heat or freeze events from our cool room to your fridge.
An alarm is triggered if a breach occurs.

Every single delivery is tracked, traced and verified

Our dedicated staff track, trace and verify every cold chain delivery, every day. Consignments are checked to ensure arrival at key destination depots.
If a delay occurs we contact the local depot. The couriers on the ground are then notified to locate and escalate the specific delivery.
We monitor the delivery until your vaccines arrive to you!

With BP & BP your vaccines arrive in peak condition.

To Purchase Influenza from BP Medical use the below links:

To order online click here: Order online

Useful Links:

RACGP Pandemic flu kit - https://www.racgp.org.au/download/Documents/Disaster/pandemicflukit.pdf

If you wish to discuss ordering, any existing orders or have further questions, please do not hesitate to contact us on 1300 33 55 60 or email This email address is being protected from spambots. You need JavaScript enabled to view it.